Bottom line
What is PTMAX's expense ratio?
PTMAX's expense ratio is 0.7%, or about $70 a year on every $10,000 invested. That is cheaper than 61% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.3% 12b-1 marketing fee.
Updated Dec 23, 2025
PTMAX fee table
| Net expense ratio | 0.7% |
|---|---|
| Gross expense ratio | 0.78% |
| Management fee | 0.35% |
| 12b-1 (distribution) fee | 0.3% |
| Other expenses | 0.13% |
| Fee waiver / reimbursement | -0.08% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 1% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What PTMAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PTMAX | $618 | $778 | $952 | $1,456 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.7% expense ratio costs roughly $39,800 in lost growth, versus about $46,700 for the median large blend fund (0.83%).
Cheaper alternatives to PTMAX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.